APOBEC3 mutagenesis drives therapy resistance in breast cancer – University of Texas 01.06.25 Further Reading APOBEC3 mutagenesis drives therapy resistance in breast cancer – University of Texas 01.06.25 Suppressing Key Enzymes Could Improve Lung Cancer Treatment Outcomes – Yale 29.04.25 A novel mechanism for evolution of drug resistance in lung cancers – Ludwig Cancer Research 05.07.23 APOBEC enzymes: Mutagenic fuel for cancer evolution and heterogeneity – The Francis Crick Institute 01.07.15